Poststroke dementia Vikas Dhikav,

Slides:



Advertisements
Similar presentations
Vascular cognitive impairment – an overview
Advertisements

 Most common and important degenerative disease of the brain  Shrinkage in size and weight of the brain  Severe degree of diffuse cerebral atrophy.
ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial The telmisartan trial in cardiovascular protection Sponsored by Boehringer.
Circulación Cerebral y Demencia Senil. Interactions between VaD and AD VaD post-stroke dementia infarcts, white matter lesions (WMLs) vascular risk factors.
Management of Early Dementia Dr Eleanor Mullan Consultant Psychiatrist Mental Health Services for Older People South Lee, Cork Feb 2011.
Stroke Research in East Kent Prevention and Treatment Present and Future Dr Tom Webb Consultant Neurologist and Stroke Physician EKHUFT June 2014.
Frontotemporal Dementia
“ Age-Related Differences in Characteristics, Performance Measures, Treatment Trends, and Outcomes in Patients with Ischemic Stroke ” Gregg C. Fonarow,
Mild Cognitive Impairment as a Target for Drug Development Steven H. Ferris, Ph.D. Silberstein Aging and Dementia Research Center New York University School.
GAL-INT-6 The safety and efficacy of galantamine in patients with Vascular dementia or AD with cerebrovascular disease Sean Lilienfeld MD, FCP, MMed Janssen.
How Alzheimer’s Disease Differs from Frontal Temporal Lobe Dementia (Pick’s Disease) Josepha A. Cheong, MD University of Florida Departments of Psychiatry.
Dr. Omranifard MD 12 may 2015 Depression is one of the most prevalent psychiatric disorders in late life with devastating health consequences. It could.
Subtype of VaD: SIVD Subcortical Ischemic Vascular Disease Helena Chui, M.D. University of Southern California Rancho Los Amigos National Rehabilitation.
Stroke - the size of the problem. What is a stroke? What is a transient ischaemic attack? What is the size of the problem?
Screening for Stroke and Cognitive Impairment Chapter 2: Background.
Alzheimer’s Disease and Biomarkers John H. Dougherty,Jr.M.D. Medical Director Cole Neuroscience Center.
Update on Hypertensive Retinopathy
VASCULAR DEMENTIA (VaD) A BRIEF REVIEW WITH SPECIAL EMPHASIS ON CURRENT CLINICAL IMPACT MURRAY FLASTER MD, PhD BARROW NEUROLOGICAL CLINIC.
1 大綱 個案報告 Quality Indicators for the Management of Medical Conditions in Nursing Home Residents Treatment and prevention of vascular dementia.
Dementia Reed Radford. What is dementia?  Dementia is a serious loss of global cognitive ability, beyond what might be expected from normal aging. 
Alzheimer’s Disease Landscape
Defining Mild Cognitive Impairment Steven T.DeKosky, M.D. Director, Alzheimer’s Disease Research Center University of Pittsburgh Pittsburgh, PA.
Menopause and the Brain: Lifting the Fog Majid Fotuhi, MD PhD.
Grow Your Brain at Any Age Majid Fotuhi, MD PhD Howard County Office on Aging Columbia, MD March 28, 2014.
Six Steps to a Better Brain Majid Fotuhi, MD PhD March 6, 2014.
Primordial, primary, secondary, and tertiary prevention stages for global vascular risk. R. Sacco: Stroke, Volume 38(6).June
Alzheimer’s Disease  Goals  To understand what dementia is  To explore causes, risk factors, symptoms, and treatments of Alzheimer’s Disease  To better.
Dementia. What is Dementia? Dementia is a gradual decline of mental ability that affects your intellectual and social skills to the point where daily.
PROGRESS PERINDOPRIL PROTECTION AGAINST RECURRENT STROKE STUDY PROGRESS Collaborative Group Institute for International Health PROGRESS.
Aim To determine the effects of a Coversyl- based blood pressure lowering regimen on the risk of recurrent stroke among patients with a history of stroke.
Is It Alzheimer’s? The Latest Update on Optimal Evaluation and Treatment of Patients with Memory Loss Majid Fotuhi, MD PhD March 5, 2014.
Peripheral and Central Nervous System Drugs Advisory Committee Meeting - March 14, Issues Related to the Development of Drugs for the Treatment.
Amyotrophic lateral sclerosis
Cognitive Disorders Chapter 13 Nature of Cognitive Disorders: An Overview Perspectives on Cognitive Disorders Cognitive processes such as learning, memory,
Background. Vascular Cognitive Impairment Vascular Cognitive Impairment (VCI) includes the cognitive and behavioural disorders associated with cerebrovascular.
Alzheimer’s Disease Stephanie Aparicio May 4, 2011 Period 5.
BY: GRACE STOUT. What is Alzheimer’s and what does it do to the human body?  Alzheimer’s Disease is a progressive, neurodegenerative disorder that is.
以多重死因資料比較台灣美國腦中風 併發吸入性肺炎之趨勢 奇美醫學中心 張嘉祐醫師. Stroke Statistics -- A Report From the American Heart Association Approximately 56% of stroke deaths in 2009.
Improvements needed in the care of people living with Dementia.
Types of Dementia Dr Bernie Coope Associate Medical Director/Honorary Senior Lecturer, Worcester University Association for Dementia Studies.
The SYMPHONY Trial Reference Reddan DN, et al. Renal function, concomitant medication use and outcomes following acute coronary syndromes. Nephrol Dial.
Dementia Dr.Mansour K. Alzahrani.  Define the dementia  Discuss the prevalence of dementia  Discuss the impact of dementia on the individual and the.
Effects of Clopidogrel Added to Aspirin
1 Predicting Dementia From Vascular Conditions Among Tennessee Medicare Elderly Baqar A. Husaini, PhD Professor & Director, Center for Health Research.
Dementia F.Etessam. MD. Dementia A progressive impairment of cognitive functions occurring in clear consciousness.
DEMENTIA 1/6/16 DR TONY O’BRIEN MD FRCP. Dementia Common – 700,000 sufferers in the UK Common – 700,000 sufferers in the UK Prevalence increases with.
The Link Between Persistent Atrial Fibrillation and Dementia
The Malfunctioning Mind: Degenerative Diseases of the Brain
Anne Moore Specialist in Special Care NHS Lanarkshire PDS
Dementia Jaqueline Raetz, M.D..
In collaboration with:
DEMENTIA Shenae Whitfield & Kate Maddock.
Antonelli D, Koren O. Rozner E. Turgeman Y.
Dementia Jaqueline Raetz, M.D..
Evidence Based Bedroom Yoga
Seizures in Alzheimer’s disease
Yard. Doç.Dr. N. Berfu AKBAŞ
Presenter : Dr Aneelraj Co investigators : Dr Srikala Bharath
DYSLIPIDEMIA AND ATHEROSCLEROSIS
Mechanisms, Clinical Significance, and Prevention of Cognitive Impairment in Patients With Atrial Fibrillation  Lena Rivard, MD, MSc, Paul Khairy, MD,
Trends in Stroke Rates, Risk, and Outcomes in the United States, 1988 to 2008  Margaret C. Fang, MD, MPH, Marcelo Coca Perraillon, MA, Kaushik Ghosh, PhD,
Assessment of BPSD Rajesh Tampi , MD Professor of Psychiatry
Rubin Becker MD FRCP© Associate Professor McGill University Medical Consultant Manulife and OptimumRe.
I Can’t Find My Keys – Should I Be Worried?
Copyright Notice This presentation is copyrighted by the Psychopharmacology Institute. Subscribers can download it and use it for professional use. The.
The Memory Assessment and Treatment Service (MATS)
Figure 2 A case of early-onset PSD
Risk Factors and Therapies for Vascular Dementia:
Association between cognitive impairment and cerebrovascular disease
Presentation transcript:

Poststroke dementia Vikas Dhikav, MBBS (Rohtak), MD (3-years AIIMS) , PhD (Neurology, PGIMER Delhi), Fellowship Clinical Neuropsychopharmacology, Director, Memory Clinic Delhi & Honorary Professor, ISM-IUK, Bishkek, Kyrgyzstan. www.memoryclinicdelhi.com vikasdhikav@hotmail.com

Post stroke dementia Dementia is one of the major causes of dependency after stroke. Having a stroke doubles the risk of dementia. Leys D et al. Lancet Neurol. 2005;4(11):752-9.

Post Stroke Dementia… Cerebrovascular disease is increasingly recognized as a common cause of cognitive impairment and dementia in later life either alone or in conjunction with other pathologies, most often Alzheimer disease. O'Brien JT. Vascular cognitive impairment. Am J Geriatr Psychiatry. 2006;14(9):724-33.

Vascular cognitive impairment Umbrella term  recognizes the broad spectrum of: Cognitive Behavioral changes associated with vascular pathology O'Brien JT. Am J Geriatr Psychiatry. 2006;14(9):724-33.

Types of VCIs Cortical Subcortical Strategic infarct Hypoperfusion Hemorrhagic Mixed (with AD) type. 

Frequency of post stroke dementia? In a recent study from Northern India, 45% frequency was found. Chaudhari TS et al., J Neurol Sci. 2014;340(1-2):150-8.

Future of post stroke dementia The prevalence of poststroke dementia -defined as any dementia occurring after stroke-is likely to increase in the future. Leys D et al. Lancet Neurol. 2005;4(11):752-9.

History Stroke was recognized as an important cause of dementia ≥1 century ago, Until the 1960s, most cases of dementia were attributed to atherosclerosis. Now cerebrovascular disease is considered to be the second most common cause of dementia Post stroke dementia is one of the rare preventable dementias. Barba R. Stroke. 2000;31(7):1494-501.

Why does VCI occur? Interaction between: Vascular risk factors Hypertension Diabetes Obesity Dyslipidemia Parenchymal brain changes Macro & Micro infarcts White matter changes Alladi S. Annals Ind Acad Neurol 2010; S-104-108.

Patient Related Predisposing factors Increasing age, low education Dependency before stroke & prestroke cognitive decline without dementia Diabetes mellitus , Atrial fibrillation, past myocardial infarction Epileptic seizures Congestive heart failure, hypertension Silent cerebral infarcts & white-matter changes Global and medial-temporal-lobe atrophy Leys D et al. Lancet Neurol. 2005;4(11):752-9.

Stroke Related Predisposing Factors Stroke severity Cause Location Recurrence

Other factors Vascular lesions Alzheimer pathology White-matter changes Or combinations of these.

Overlap? Patients who had a stroke and medial temporal lobe atrophy (MTA) more frequently develop dementia than patients without MTA  Cordoliani-Mackowiak MA. Arch Neurol. 2003;60(4):585-90.

Indian experience Older age at first-ever stroke and cortical atrophy are associated with increased risk for dementia  Das S. Cognitive dysfunction in stroke survivors: a community-based prospective study from Kolkata, India. J Stroke Cerebrovasc Dis. 2013;22(8):1233-42.

Functional outcome? Poor! Barba R. Stroke. 2000;31(7):1494-501; Alladi S. Annals Ind Acad Neurol 2010; S-104-108.

Mortality? Patients with PSD have high mortality rates and are likely to be functionally impaired. Leys D et al., Lancet Neurol. 2005;4(11):752-9.

VCI?/Poststroke?/Vascular? Vascular cognitive impairment (VCI)  entire spectrum of cognitive impairment occurring as a result of cerebrovascular disease. VCI encompasses not only vascular dementia (VaD), but also mixed dementia and vascular cognitive impairment-no dementia (VCI-ND). VCI-ND refers to that subgroup of patients who manifest cognitive deficits resulting from cerebrovascular disease, but do not meet the definition of dementia. 

Main Types Multi-infarct dementia (MID) Subcortical ischaemic vascular disease (SIVD) Strategic infarct subtypes of poststroke VCI 

Post stroke depression Depression was found to be the commonest symptom, irrespective of the subtype or severity of VCI. Gupta M. Behav Neurol. 2014;2014:430128.

BPSD 95% of cases had at least one neuropsychiatric symptom, with depression being the commonest, irrespective of subtype or severity of VCI. Strategic infarct patients had the lowest frequency of all symptoms. Gupta M. Behav Neurol. 2014;2014:430128.

Survival following stroke dementia? Around 3 years! http://www.alz.org/dementia/vascular-dementia-symptoms.asp

Drug treatment No special drug has been approved for vascular dementia. Drugs effective in Alzheimer’s are modestly effective in vascular dementias as well. http://www.alz.org/dementia/vascular-dementia-symptoms.asp

Gaps There remain fundamental gaps in our understanding of pathophysiology, predicting prognosis and outcome, and in therapeutics.  O'Brien JT. Am J Geriatr Psychiatry. 2006;14(9):724-33.

Challenges in post stroke dementias Clinical Trials, mainly in populations selected using currently accepted criteria for vascular dementia, have generally not been encouraging. O'Brien JT. Am J Geriatr Psychiatry. 2006;14(9):724-33.

Management Definitive treatment Control of risk factors e.g. Nimodipine Memantine Cholinesterase inhibitors Control of risk factors e.g. Diabetes Hypertension Hyperlipidemia  

Prevention It is important identify patients at early stages of cognitive impairment, to treat appropriately and prevent progression to frank dementia. Alladi S. Annals Ind Acad Neurol 2010; S-104-108.

Thank you